Organon (OGN) Inventory Average (2021 - 2026)
Organon (OGN) posted quarterly Inventory Average of $1.4 billion for Q2 2026, down 3.27% year-over-year from $1.4 billion in Q2 2025, and down 1.98% on a QoQ basis from $1.4 billion in Q1 2026.
Organon (OGN) Inventory Average (2021 - 2026) Analysis & Trends
Organon has reported Inventory Average for 6 years, with the latest figure at $1.4 billion in Q2 2026.
- Inventory Average for Q2 2026 came in at $1.4 billion, down 3.27% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.4 billion (down 3.27% YoY), and the FY2025 annual result was $1.4 billion, up 3.45% from the prior year.
- Inventory Average fell to $1.4 billion in Q2 2026, from $1.4 billion in the prior quarter.
- Over five years, Inventory Average peaked at $1.5 billion in Q3 2025 and troughed at $914.5 million in Q3 2022.
- A 5-year average of $1.2 billion and a median of $1.3 billion in 2024 frame the typical range for Inventory Average.
- The widest annual swing landed in 2023, when Inventory Average soared 32.89%; it then declined 3.27% in 2026.
- A 5-year view of Inventory Average shows it stood at $941.0 million in 2022, then soared by 32.89% to $1.3 billion in 2023, then climbed by 8.12% to $1.4 billion in 2024, then gained by 7.03% to $1.4 billion in 2025, then declined by 5.87% to $1.4 billion in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $1.4 billion in Q2 2026, $1.4 billion in Q1 2026, and $1.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 1.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Bn |
| Mar 31, 2026 | 1.39 Bn |
| Dec 31, 2025 | 1.45 Bn |
| Sep 30, 2025 | 1.47 Bn |
| Jun 30, 2025 | 1.41 Bn |
| Mar 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Sep 30, 2024 | 1.34 Bn |
| Jun 30, 2024 | 1.28 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Mar 31, 2023 | 1.06 Bn |
| Dec 31, 2022 | 941.00 Mn |
| Sep 30, 2022 | 914.50 Mn |
| Jun 30, 2022 | 948.00 Mn |
| Mar 31, 2022 | 930.50 Mn |
| Dec 31, 2021 | 916.50 Mn |
| Sep 30, 2021 | 894.50 Mn |